1. HIV-1 Proviral Sequence and Treatment Outcome of Virologically Suppressed Patients Switching to Coformulated Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate. (1st September 2018) Authors: Andreatta, Kristen; Chang, Silvia; Martin, Ross; Acosta, Rima; Daeumer, Martin; Thielen, Alexander; Miller, Michael D.; White, Kirsten L. Journal: Journal of acquired immune deficiency syndromes Issue: Volume 79:Number 1(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment–Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide. (30th January 2017) Authors: Margot, Nicolas A.; Wong, Pamela; Kulkarni, Rima; White, Kirsten; Porter, Danielle; Abram, Michael E.; Callebaut, Christian; Miller, Michael D. Journal: Journal of infectious diseases Issue: Volume 215:Number 6(2017:Mar. 15) Page Start: 920 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Discovery and optimization of 2-pyridinone aminal integrase strand transfer inhibitors for the treatment of HIV. Issue 9 (1st May 2017) Authors: Schreier, John D.; Embrey, Mark W.; Raheem, Izzat T.; Barbe, Guillaume; Campeau, Louis-Charles; Dubost, David; McCabe Dunn, Jamie; Grobler, Jay; Hartingh, Timothy J.; Hazuda, Daria J.; Klein, Daniel; Miller, Michael D.; Moore, Keith P.; Nguyen, Natalie; Pajkovic, Natasa; Powell, David A.; Rada, V... Journal: Bioorganic & medicinal chemistry letters Issue: Volume 27:Issue 9(2017) Page Start: 2038 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Clinical Outcomes of Virologically-Suppressed Patients with Pre-existing HIV-1 Drug Resistance Mutations Switching to Rilpivirine/Emtricitabine/Tenofovir Disoproxil Fumarate in the SPIRIT Study*. Issue 1 (2nd January 2016) Authors: Porter, Danielle P.; Toma, Jonathan; Tan, Yuping; Solberg, Owen; Cai, Suqin; Kulkarni, Rima; Andreatta, Kristen; Lie, Yolanda; Chuck, Susan K.; Palella, Frank; Miller, Michael D.; White, Kirsten L. Journal: HIV clinical trials Issue: Volume 17:Issue 1(2016) Page Start: 29 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Repeat testing of low-level HIV-1 RNA: assay performance and implementation in clinical trials. (15th May 2018) Authors: White, Kirsten; Garner, Will; Wei, Lilian; Eron, Joseph J.; Zhong, Lijie; Miller, Michael D.; Martin, Hal; Plummer, Andrew; Tran-Muchowski, Cecilia; Lindstrom, Kim; Porter, James; Piontkowsky, David; Light, Angela; Reiske, Heinz; Quirk, Erin Journal: AIDS Issue: Volume 32:Number 8(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Week 48 resistance analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF versus Atazanavir + Ritonavir + Emtricitabine/Tenofovir DF in HIV-1 infected women (WAVES study GS-US-236-0128). Issue 4 (4th July 2017) Authors: Kulkarni, Rima; Hodder, Sally L.; Cao, Huyen; Chang, Silvia; Miller, Michael D.; White, Kirsten L. Journal: HIV clinical trials Issue: Volume 18:Issue 4(2017) Page Start: 164 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Week 144 Resistance Analysis of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Atazanavir+Ritonavir+Emtricitabine/Tenofovir DF in Antiretroviral-Naïve Patients. Issue 5 (September 2014) Authors: Kulkarni, Rima; Abram, Michael E.; McColl, Damian J.; Barnes, Tiffany; Fordyce, Marshall W.; Szwarcberg, Javier; Cheng, Andrew K.; Miller, Michael D.; White, Kirsten L. Journal: HIV clinical trials Issue: Volume 15:Issue 5(2014) Page Start: 218 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. 96-week resistance analyses of the STaR study: rilpivirine/emtricitabine/tenofovir DF versus efavirenz/emtricitabine/tenofovir DF in antiretroviral-naive, HIV-1-infected subjects. Issue 1 (February 2015) Authors: Porter, Danielle P.; Kulkarni, Rima; Fralich, Todd; Miller, Michael D.; White, Kirsten L. Journal: HIV clinical trials Issue: Volume 16:Issue 1(2015) Page Start: 30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Characterization of hepatitis C virus intergenotypic recombinant strains and associated virological response to sofosbuvir/ribavirin. Issue 2 (15th December 2014) Authors: Hedskog, Charlotte; Doehle, Brian; Chodavarapu, Krishna; Gontcharova, Viktoria; Crespo Garcia, Javier; De Knegt, Robert; Drenth, Joost P.H; McHutchison, John G.; Brainard, Diana; Stamm, Luisa M.; Miller, Michael D.; Svarovskaia, Evguenia; Mo, Hongmei Journal: Hepatology Issue: Volume 61:Issue 2(2015:Feb.) Page Start: 471 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Evaluation of HBV DNA decay kinetics in patients containing both rtM204V/I mutant and wild‐type HBV subpopulations during tenofovir DF (TDF) monotherapy or combination therapy with emtricitabine (FTC)/TDF. Issue 9 (23rd May 2014) Authors: Liu, Yang; Fung, Scott; Gane, Edward J.; Dinh, Phillip; Flaherty, John F.; Svarovskaia, Evguenia S.; Miller, Michael D.; Kitrinos, Kathryn M. Journal: Journal of medical virology Issue: Volume 86:Issue 9(2014:Sep.) Page Start: 1473 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗